# Karyopharm Therapeutics Inc.: Form 8-K, filed Oct 14, 2025

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2025-10-14
- Accepted by EDGAR: Oct 14, 2025, 16:11 ET
- Period: 2025-10-10
- Accession: 0001193125-25-239015
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000119312525239015/d81116d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000119312525239015/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000119312525239015/d81116d8k.htm

Filed Oct 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-239015. Last ingested by Listed: Nov 5, 2026, 11:51 ET. No prices; not investment advice.